Bioventix (LON:BVXP) Reaches New 1-Year Low – Should You Sell?

Bioventix PLC (LON:BVXPGet Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 2,650 ($34.45) and last traded at GBX 2,698 ($35.08), with a volume of 24322 shares trading hands. The stock had previously closed at GBX 2,775 ($36.08).

Bioventix Stock Down 2.8 %

The firm has a market capitalization of £141.28 million, a P/E ratio of 17.45 and a beta of 0.35. The company’s 50 day moving average is GBX 2,998.56 and its 200-day moving average is GBX 3,444.08.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

Featured Articles

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.